banner
patentdefenses.bsky.social
@patentdefenses.bsky.social
Free, mobile-friendly compendium of substantive U.S. utility patent law decisions of Fed. Cir. and S. Ct., started in 2004 and updated about weekly, at www.patentdefenses.com
... and not stipulate to infringement without considering RDOE
January 13, 2025 at 12:44 AM
patents' claims directed to improvements in metered-dose inhalers and do not require the presence of an active drug, let alone the NDA’s active drug).
December 22, 2024 at 7:34 PM
patents' claims directed to improvements in metered-dose inhalers and do not require the presence of an active drug, let alone the NDA’s active drug).
December 22, 2024 at 7:30 PM
I asked our dog, Waggles, and cat, YoYo, and consensus answer, after some thoughtful scratching, is ... No.
December 2, 2024 at 4:32 PM
Hot topic! Will you discuss Scott Paper (U.S. 11/13/1945) (“the patent laws preclude the patentee of an expired patent and all others … from recapturing any part of the former patent monopoly; for those laws dedicate to all the public the ideas and inventions embodied in an expired patent.")?
November 29, 2024 at 6:01 PM
is admissibility issue for trial judge ... not merely for jury to determine weight of evidence. Uber argues RR is limited to compensatory damages, not disgorgement of profits, and thus “comparable” licenses admissible only if create “established royalty” or if offered by defendant as cap on RR.
November 27, 2024 at 8:07 PM
Doggyphone (Fed. Cir. 11/21/21) cafc.uscourts.gov/opinions-ord...
cafc.uscourts.gov
November 21, 2024 at 6:13 PM